Mitochondrial contribution to parkinson's disease pathogenesis

Parkinson's Disease

Volumn , Issue , 2011, Pages

  Schapira, Anthony H V ^a   Gegg, Matthew ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; DJ 1 PROTEIN; DNA DIRECTED DNA POLYMERASE GAMMA; PARKIN; PARKIN 2; PARKIN 6; SERINE PROTEINASE OMI; UNCLASSIFIED DRUG;

AUTOPHAGY; AUTOSOMAL RECESSIVE DISORDER; AUTOSOMAL RECESSIVE JUVENILE ONSET PARKINSONISM; CELL FUNCTION; CELL STRUCTURE; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GENE MUTATION; MITOCHONDRION; MOLECULAR DYNAMICS; PARKINSON DISEASE; PARKINSONISM; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

EID: 79959242100     PISSN: None     EISSN: 20420080     Source Type: Journal    
DOI: 10.4061/2011/159160     Document Type: Review

References (120)

1. Schapira A. H., Mitochondrial disease Lancet 2006 368 9529 70 82 (Pubitemid 43947206)
2. Leonard J. V., Schapira A. H. V., Mitochondrial respiratory chain disordersI: mitochondrial DNA defects Lancet 2000 355 9200 299 304 (Pubitemid 30068529)
3. Leonard J. V., Schapira A. H. V., Mitochondrial respiratory chain disordersII: neurodegenerative disorders and nuclear gene defects Lancet 2000 355 9201 389 394
4. Schapira A. H. V., Cooper J. M., Dexter D., Jenner P., Clark J. B., Marsden C. D., Mitochondrial complex I deficiency in Parkinson's disease Lancet 1989 1 8649 1269 (Pubitemid 19140359)
5. Schapira A. H. V., Evidence for mitochondrial dysfunction in Parkinson's diseasea critical appraisal Movement Disorders 1994 9 2 125 138 (Pubitemid 24092327)
6. Schapira A. H. V., Cooper J. M., Dexter D., Clark J. B., Jenner P., Marsden C. D., Mitochondrial Complex I deficiency in Parkinson's disease Journal of Neurochemistry 1990 54 3 823 827
7. Schapira A. H. V., Mann V. M., Cooper J. M., Dexter D., Daniel S. E., Jenner P., Clark J. B., Marsden C. D., Anatomic and disease specificity of NADH CoQ reductase (complex I) deficiency in Parkinson's disease Journal of Neurochemistry 1990 55 6 2142 2145 (Pubitemid 120021853)
8. Parker W. D. Jr., Parks J. K., Swerdlow R. H., Complex I deficiency in Parkinson's disease frontal cortex Brain Research 2008 1189 1 215 218 (Pubitemid 351842538)
9. Dexter D. T., Jenner P., Schapira A. H.V., Marsden C. D., Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia Annals of Neurology 1992 32, supplement S94 S100
10. Mann V. M., Cooper J. M., Daniel S. E., Srai K., Jenner P., Marsden C. D., Schapira A. H. V., Complex I, iron, and ferritin in Parkinson's disease substantia nigra Annals of Neurology 1994 36 6 876 881 (Pubitemid 24370927)
11. Schapira A. H. V., Oxidative stress in Parkinson's disease Neuropathology and Applied Neurobiology 1995 21 1 3 9
12. Owen A. D., Schapira A. H. V., Jenner P., Marsden C. D., Oxidative stress and Parkinson's disease Annals of the New York Academy of Sciences 1996 786 217 223 (Pubitemid 26273166)
13. Gu M., Owen A. D., Toffa S. E. K., Cooper J. M., Dexter D. T., Jenner P., Marsden C. D., Schapira A. H. V., Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases Journal of the Neurological Sciences 1998 158 1 24 29 (Pubitemid 28277530)
14. Olanow C. W., A radical hypothesis for neurodegeneration Trends in Neurosciences 1993 16 11 439 444 (Pubitemid 23313517)
15. Morgan-Hughes J. A., Sweeney M. G., Cooper J. M., Hammans S. R., Brockington M., Schapira A. H. V., Harding A. E., Clark J. B., Mitochondrial DNA (mtDNA) diseases: correlation of genotype to phenotype Biochimica et Biophysica Acta 1995 1271 1 135 140
16. Thyagarajan D., Bressman S., Bruno C., Przedborski S., Shanske S., Lynch T., Fahn S., Dimauro S., A novel mitochondrial 12SrRNA point mutation in parkinsonism, deafness, and neuropathy Annals of Neurology 2000 48 5 730 736
17. Morgan-Hughes J. A., Schapira A. H. V., Cooper J. M., Clark J. B., Molecular defects of NADH-ubiquinone oxidoreductase (Complex I) in mitochondrial diseases Journal of Bioenergetics and Biomembranes 1988 20 3 365 382
18. Schapira A. H. V., Cooper J. M., Morgan-Hughes J. A., Patel S. D., Cleeter M. J. W., Ragan C. I., Clark J. B., Molecular basis of mitochondrial myopathies: polypeptide analysis in complex-I deficiency Lancet 1988 1 8584 500 503 (Pubitemid 18059684)
19. Hanna M. G., Nelson I. P., Rahman S., Lane R. J. M., Land J., Heales S., Cooper M. J., Schapira A. H. V., Morgan-Hughes J. A., Wood N. W., Cytochrome c oxidase deficiency associated with the first stop-codon point mutation in human mtDNA American Journal of Human Genetics 1998 63 1 29 36 (Pubitemid 30428314)
20. Rahman S., Taanman J. W., Cooper J. M., Nelson I., Hargreaves I., Meunier B., Hanna M. G., Garca J. J., Capaldi R. A., Lake B. D., Leonard J. V., Schapira A. H. V., A missense mutation of cytochrome oxidase subunit II causes defective assembly and myopathy American Journal of Human Genetics 1999 65 4 1030 1039 (Pubitemid 30462959)
21. Mancuso M., Filosto M., Oh S. J., DiMauro S., A novel polymerase mutation in a family with ophthalmoplegia, neuropathy, and parkinsonism Archives of Neurology 2004 61 11 1777 1779 (Pubitemid 39463436)
22. Davidzon G., Greene P., Mancuso M., Klos K. J., Ahlskog J. E., Hirano M., DiMauro S., Early-onset familial parkinsonism due to POLG mutations Annals of Neurology 2006 59 5 859 862 (Pubitemid 43673164)
23. Luoma P., Melberg A., Rinne J. O., Kaukonen J. A., Nupponen N. N., Chalmers R. M., Oldfors P. A., Rautakorpi I., Peltonen P. L., Majamaa P. K., Somer H., Suomalainen A., Parkinsonism, premature menopause, and mitochondrial DNA polymerase mutations: clinical and molecular genetic study Lancet 2004 364 9437 875 882 (Pubitemid 39221065)
24. Morris A. A. M., Taanman J. W., Blake J., Mark Cooper J., Lake B. D., Malone M., Love S., Clayton P. T., Leonard J. V., Schapira A. H. V., Liver failure associated with mitochondrial DNA depletion Journal of Hepatology 1998 28 4 556 563 (Pubitemid 28167992)
25. Taanman J. W., Rahman S., Pagnamenta A. T., Morris A. A. M., Bitner-Glindzicz M., Wolf N. I., Leonard J. V., Clayton P. T., Schapira A. H. V., Analysis of mutant DNA polymerase in patients with mitochondrial DNA depletion Human Mutation 2009 30 2 248 254
26. Taanman J. W., Schapira A. H. V., Analysis of the trinucleotide CAG repeat from the DNA polymerase gene (POLG) in patients with Parkinson's disease Neuroscience Letters 2005 376 1 56 59 (Pubitemid 40202937)
27. Hudson G., Schaefer A. M., Taylor R. W., Tiangyou W., Gibson A., Venables G., Griffiths P., Burn D. J., Turnbull D. M., Chinnery P. F., Mutation of the linker region of the polymerase -1 (POLG1) gene associated with progressive external ophthalmoplegia and parkinsonism Archives of Neurology 2007 64 4 553 557 (Pubitemid 46588345)
28. Cooper J. M., Mann V. M., Schapira A. H. V., Analyses of mitochondrial respiratory chain function and mitochondrial DNA deletion in human skeletal muscle: effect of ageing Journal of the Neurological Sciences 1992 113 1 91 98
29. Mann V. M., Cooper J. M., Schapira A. H. V., Quantitation of a mitochondrial DNA deletion in Parkinson's disease FEBS Letters 1992 299 3 218 222
30. Kraytsberg Y., Kudryavtseva E., McKee A. C., Geula C., Kowall N. W., Khrapko K., Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons Nature Genetics 2006 38 5 518 520
31. Bender A., Krishnan K. J., Morris C. M., Taylor G. A., Reeve A. K., Perry R. H., Jaros E., Hersheson J. S., Betts J., Klopstock T., Taylor R. W., Turnbull D. M., High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease Nature Genetics 2006 38 5 515 517
32. Chan C. S., Guzman J. N., Ilijic E., Mercer J. N., Rick C., Tkatch T., Meredith G. E., Surmeier D. J., Rejuvenation protects neurons in mouse models of Parkinson's disease Nature 2007 447 7148 1081 1086 (Pubitemid 47014425)
33. Surmeier D. J., Guzman J. N., Sanchez-Padilla J., Calcium, cellular aging, and selective neuronal vulnerability in Parkinson's disease Cell Calcium 2010 47 2 175 182
34. Swerdlow R. H., Parks J. K., Cassarino D. S., Binder D. R., Bennett J. P., Di Iorio G., Golbe L. I., Parker W. D., Biochemical analysis of cybrids expressing mitochondrial DNA from Contursi kindred Parkinson's subjects Experimental Neurology 2001 169 2 479 485 (Pubitemid 32536740)
35. Borland M. K., Mohanakumar K. P., Rubinstein J. D., Keeney P. M., Xie J., Capaldi R., Dunham L. D., Trimmer P. A., Bennett J. P., Relationships among molecular genetic and respiratory properties of Parkinson's disease cybrid cells show similarities to Parkinson's brain tissues Biochimica et Biophysica Acta 2009 1792 1 68 74
36. Trimmer P. A., Swerdlow R. H., Parks J. K., Keeney P., Bennett J. P., Miller S. W., Davis R. E., Parker W. D., Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines Experimental Neurology 2000 162 1 37 50 (Pubitemid 30170099)
37. Gu M., Cooper J. M., Taanman J. W., Schapira A. H. V., Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease Annals of Neurology 1998 44 2 177 186 (Pubitemid 28374105)
38. Valente E. M., Abou-Sleiman P. M., Caputo V., Muqit M. M. K., Harvey K., Gispert S., Ali Z., Del Turco D., Bentivoglio A. R., Healy D. G., Albanese A., Nussbaum R., Gonzlez-Maldonado R., Deller T., Salvi S., Cortelli P., Gilks W. P., Latchman D. S., Harvey R. J., Dallapiccola B., Auburger G., Wood N. W., Hereditary early-onset Parkinson's disease caused by mutations in PINK1 Science 2004 304 5674 1158 1160 (Pubitemid 38661852)
39. Gautier C. A., Kitada T., Shen J., Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress Proceedings of the National Academy of Sciences of the United States of America 2008 105 32 11364 11369
40. Gandhi S., Wood-Kaczmar A., Yao Z., Plun-Favreau H., Deas E., Klupsch K., Downward J., Latchman D. S., Tabrizi S. J., Wood N. W., Duchen M. R., Abramov A. Y., PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death Molecular Cell 2009 33 5 627 638
41. Gegg M. E., Cooper J. M., Schapira A. H. V., Taanman J. W., Silencing of PINK1 expression affects mitochondrial DNA and oxidative phosphorylation in DOPAMINERGIC cells PLoS ONE 2009 4 3, article e4756
42. Hoepken H. H., Gispert S., Morales B., Wingerter O., Del Turco D., Mlsch A., Nussbaum R. L., Mller K., Drse S., Brandt U., Deller T., Wirth B., Kudin A. P., Kunz W. S., Auburger G., Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6 Neurobiology of Disease 2007 25 2 401 411 (Pubitemid 46124020)
43. Piccoli C., Sardanelli A., Scrima R., Ripoli M., Quarato G., D'Aprile A., Bellomo F., Scacco S., De Michele G., Filla A., Iuso A., Boffoli D., Capitanio N., Papa S., Mitochondrial respiratory dysfunction in familiar Parkinsonism associated with PINK1 mutation Neurochemical Research 2008 33 12 2565 2574
44. Grnewald A., Gegg M. E., Taanman J. W., King R. H., Kock N., Klein C., Schapira A. H. V., Differential effects of PINK1 nonsense and missense mutations on mitochondrial function and morphology Experimental Neurology 2009 219 1 266 273
45. Gispert S., Ricciardi F., Kurz A., Azizov M., Hoepken H. H., Becker D., Voos W., Leuner K., Mller W. E., Kudin A. P., Kunz W. S., Zimmerman A., Roeper J., Wenzel D., Jendrach M., Garca-Arencbia M., Fernndez-Ruiz J., Huber L., Rohrer H., Barrera M., Reichert A. S., Rb U., Chen A., Nussbaum R. L., Auburger G., Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration PLoS ONE 2009 4 6, article e5777
46. Valente E. M., Salvi S., Ialongo T., Marongiu R., Elia A. E., Caputo V., Romito L., Albanese A., Dallapiccola B., Bentivoglio A. R., PINK1 mutations are associated with sporadic early-onset Parkinsonism Annals of Neurology 2004 56 3 336 341 (Pubitemid 39166552)
47. Hatano Y., Li Y., Sato K., Asakawa S., Yamamura Y., Tomiyama H., Yoshino H., Asahina M., Kobayashi S., Hassin-Baer S., Lu C. S., Ng A. R., Rosales R. L., Shimizu N., Toda T., Mizuno Y., Hattori N., Novel PINK1 mutations in early-onset parkinsonism Annals of Neurology 2004 56 3 424 427 (Pubitemid 39166562)
48. Roh C. F., Montagna P., Breedveld G., Cortelli P., Oostra B. A., Bonifati V., Homozygous PINK1 C-terminus mutation causing early-onset parkinsonism Annals of Neurology 2004 56 3 427 431 (Pubitemid 39166563)
49. Capaldi R. A., Marusich M. F., Taanman J. W., Mammalian cytochrome-c oxidase: characterization of enzyme and immunological detection of subunits in tissue extracts and whole cells Methods in Enzymology 1995 260 117 132
50. Taanman J. W., Burton M. D., Marusich M. F., Kennaway N. G., Capaldi R. A., Subunit specific monoclonal antibodies show different steady-state levels of various cytochrome-c oxidase subunits in chronic progressive external ophthalmoplegia Biochimica et Biophysica Acta 1996 1315 3 199 207 (Pubitemid 26128328)
51. Schulenberg B., Aggeler R., Beechem J. M., Capaldi R. A., Patton W. F., Analysis of steady-state protein phosphorylation in mitochondria using a novel fluorescent phosphosensor dye Journal of Biological Chemistry 2003 278 29 27251 27255 (Pubitemid 36876882)
52. Chen R., Fearnley I. M., Peak-Chew S. Y., Walker J. E., The phosphorylation of subunits of complex i from bovine heart mitochondria Journal of Biological Chemistry 2004 279 25 26036 26045 (Pubitemid 38798746)
53. Murray J., Marusich M. F., Capaldi R. A., Aggeler R., Focused proteomics: monoclonal antibody-based isolation of the oxidative phosphorylation machinery and detection of phosphoproteins using a fluorescent phosphoprotein gel stain Electrophoresis 2004 25 15 2520 2525 (Pubitemid 39193661)
54. Schulenberg B., Goodman T. N., Aggeler R., Capaldi R. A., Patton W. F., Characterization of dynamic and steady-state protein phosphorylation using a fluorescent phosphoprotein gel stain and mass spectrometry Electrophoresis 2004 25 15 2526 2532 (Pubitemid 39193662)
55. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism Nature 1998 392 6676 605 608 (Pubitemid 28207717)
56. Takahashi H., Ohama E., Suzuki S., Horikawa Y., Ishikawa A., Morita T., Tsuji S., Ikuta F., Familial juvenile parkinsonism: clinical and pathologic study in a family Neurology 1994 44 3 I 437 441 (Pubitemid 24098141)
57. Farrer M., Chan P., Chen R., Tan L., Lincoln S., Hernandez D., Forno L., Gwinn-Hardy K., Petrucelli L., Hussey J., Singleton A., Tanner C., Hardy J., Langston J. W., Lewy bodies and parkinsonism in families with parkin mutations Annals of Neurology 2001 50 3 293 300 (Pubitemid 32848731)
58. Pramstaller P. P., Schlossmacher M. G., Jacques T. S., Scaravilli F., Eskelson C., Pepivani I., Hedrich K., Adel S., Gonzales-McNeal M., Hilker R., Kramer P. L., Klein C., Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers Annals of Neurology 2005 58 3 411 422 (Pubitemid 41266627)
59. Hattori N., Kitada T., Matsumine H., Asakawa S., Yamamura Y., Yoshino H., Kobayashi T., Yokochi M., Wang M., Yoritaka A., Kondo T., Kuzuhara S., Nakamura S., Shimizu N., Mizuno Y., Molecular genetic analysis of a novel Parkin gene in Japanese families with autosomal recessive juvenile parkinsonism: evidence for variable homozygous deletions in the Parkin gene in affected individuals Annals of Neurology 1998 44 6 935 941 (Pubitemid 28558255)
60. Abbas N., Lcking C. B., Ricard S., Drr A., Bonifati V., De Michele G., Bouley S., Vaughan J. R., Gasser T., Marconi R., Broussolle E., Brefel-Courbon C., Harhangi B. S., Oostra B. A., Fabrizio E., Bhme G. A., Pradier L., Wood N. W., Filla A., Meco G., Denefle P., Agid Y., Brice A., A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe Human Molecular Genetics 1999 8 4 567 574 (Pubitemid 29139969)
61. Wang Y., Clark L. N., Louis E. D., Mejia-Santana H., Harris J., Cote L. J., Waters C., Andrews H., Ford B., Frucht S., Fahn S., Ottman R., Rabinowitz D., Marder K., Risk of Parkinson disease in carriers of Parkin mutations: estimation using the kin-cohort method Archives of Neurology 2008 65 4 467 474 (Pubitemid 351549954)
62. West A., Periquet M., Lincoln S., Lcking C. B., Nicholl D., Bonifati V., Rawal N., Gasser T., Lohmann E., Deleuze J. F., Maraganore D., Levey A., Wood N., Drr A., Hardy J., Brice A., Farrer M., Complex relationship between Parkin mutations and Parkinson disease American Journal of Medical Genetics 2002 114 5 584 591 (Pubitemid 34680590)
63. Shimura H., Hattori N., Kubo S. I., Mizuno Y., Asakawa S., Minoshima S., Shimizu N., Iwai K., Chiba T., Tanaka K., Suzuki T., Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase Nature Genetics 2000 25 3 302 305 (Pubitemid 30437317)
64. Zhang Y., Gao J., Chung K. K. K., Huang H., Dawson V. L., Dawson T. M., Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1 Proceedings of the National Academy of Sciences of the United States of America 2000 97 24 13354 13359
65. Chin L. S., Olzmann J. A., Li L., Parkin-mediated ubiquitin signalling in aggresome formation and autophagy Biochemical Society Transactions 2010 38 1 144 149
66. Palacino J. J., Sagi D., Goldberg M. S., Krauss S., Motz C., Wacker M., Klose J., Shen J., Mitochondrial dysfunction and oxidative damage in parkin-deficient mice Journal of Biological Chemistry 2004 279 18 18614 18622 (Pubitemid 38623283)
67. Greene J. C., Whitworth A. J., Kuo I., Andrews L. A., Feany M. B., Pallanck L. J., Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants Proceedings of the National Academy of Sciences of the United States of America 2003 100 7 4078 4083 (Pubitemid 36418160)
68. Darios F., Corti O., Lcking C. B., Hampe C., Muriel M. P., Abbas N., Gu W. J., Hirsch E. C., Rooney T., Ruberg M., Brice A., Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death Human Molecular Genetics 2003 12 5 517 526 (Pubitemid 36305590)
69. Muftuoglu M., Elibol B., Dalmizrak O., Ercan A., Kulaksiz G., gs H., Dalkara T., zer N., Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations Movement Disorders 2004 19 5 544 548
70. Mortiboys H., Thomas K. J., Koopman W. J. H., Klaffke S., Abou-Sleiman P., Olpin S., Wood N. W., Willems P. H. G. M., Smeitink J. A. M., Cookson M. R., Bandmann O., Mitochondrial function and morphology are impaired in parkin-mutant fibroblasts Annals of Neurology 2008 64 5 555 565
71. Grnewald A., Voges L., Rakovic A., Kasten M., Vandebona H., Hemmelmann C., Mutant parkin impairs mitochondrial function and morphology in human fibroblasts PLoS ONE 2010 5 9, article e12962
72. Junn E., Jang W. H., Zhao X., Jeong B. S., Mouradian M. M., Mitochondrial localization of DJ-1 leads to enhanced neuroprotection Journal of Neuroscience Research 2009 87 1 123 129
73. Fan J., Ren H., Jia N., Fei E., Zhou T., Jiang P., Wu M., Wang G., DJ-1 decreases Bax expression through repressing p53 transcriptional activity Journal of Biological Chemistry 2008 283 7 4022 4030
74. Zhong N., Xu J., Synergistic activation of the human MnSOD promoter by DJ-1 and PGC-1 : regulation by SUMOylation and oxidation Human Molecular Genetics 2008 17 21 3357 3367
75. Van Der Brug M. P., Blackinton J., Chandran J., Hao L. Y., Lal A., Mazan-Mamczarz K., Martindale J., Xie C., Ahmad R., Thomas K. J., Beilina A., Gibbs J. R., Ding J., Myers A. J., Zhan M., Cai H., Bonini N. M., Gorospe M., Cookson M. R., RNA binding activity of the recessive parkinsonism protein DJ-1 supports involvement in multiple cellular pathways Proceedings of the National Academy of Sciences of the United States of America 2008 105 29 10244 10249
76. Guzman J. N., Sanchez-Padilla J., Wokosin D., Kondapalli J., Ilijic E., Schumacker P. T., Surmeier D. J., Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1 Nature 2010 468 7324 696 700
77. Batelli S., Albani D., Rametta R., Polito L., Prato F., Pesaresi M., Negro A., Forloni G., DJ-1 modulates -synuclein aggregation state in a cellular model of oxidative stress: relevance for Parkinson's Disease and involvement of HSP70 PLoS ONE 2008 3 4, article e1884
78. Polymeropoulos M. H., Lavedan C., Leroy E., Ide S. E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E. S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W. G., Lazzarini A. M., Duvoisin R. C., Di Iorio G., Golbe L. I., Nussbaum R. L., Mutation in the -synuclein gene identified in families with Parkinson's disease Science 1997 276 5321 2045 2047 (Pubitemid 27443610)
79. Krger R., Kuhn W., Mller T., Woitalla D., Graeber M., Ksel S., Przuntek H., Epplen J. T., Schls L., Riess O., Ala30Pro mutation in the gene encoding -synuclein in Parkinson's disease Nature Genetics 1998 18 2 106 108
80. Singleton A. B., Farrer M., Johnson J., Singleton A., Hague S., Kachergus J., Hulihan M., Peuralinna T., Dutra A., Nussbaum R., Lincoln S., Crawley A., Hanson M., Maraganore D., Adler C., Cookson M. R., Muenter M., Baptista M., Miller D., Blancato J., Hardy J., Gwinn-Hardy K., α-synuclein locus triplication causes Parkinson's disease Science 2003 302 5646 841 (Pubitemid 37339619)
81. Farrer M., Kachergus J., Forno L., Lincoln S., Wang D. S., Hulihan M., Maraganore D., Gwinn-Hardy K., Wszolek Z., Dickson D., Langston J. W., Comparison of kindreds with Parkinsonism and -synuclein genomic multiplications Annals of Neurology 2004 55 2 174 179 (Pubitemid 38166993)
82. Zarranz J. J., Alegre J., Gmez-Esteban J. C., Lezcano E., Ros R., Ampuero I., Vidal L., Hoenicka J., Rodriguez O., Atars B., Llorens V., Gomez Tortosa E., Del Ser T., Muoz D. G., De Yebenes J. G., The new mutation, E46K, of -synuclein causes Parkinson and lewy body dementia Annals of Neurology 2004 55 2 164 173 (Pubitemid 38166992)
83. Spillantini M. G., Schmidt M. L., Lee V. M. Y., Trojanowski J. Q., Jakes R., Goedert M., α-synuclein in Lewy bodies Nature 1997 388 6645 839 840
84. Li W. W., Yang R., Guo J. C., Ren H. M., Zha X. L., Cheng J. S., Cai D. F., Localization of α-synuclein to mitochondria within midbrain of mice NeuroReport 2007 18 15 1543 1546 (Pubitemid 47476380)
85. Nakamura K., Nemani V. M., Wallender E. K., Kaehlcke K., Ott M., Edwards R. H., Optical reporters for the conformation of -synuclein reveal a specific interaction with mitochondria Journal of Neuroscience 2008 28 47 12305 12317
86. Liu G., Zhang C., Yin J., Li X., Cheng F., Li Y., Yang H., Uda K., Chan P., Yu S., α-Synuclein is differentially expressed in mitochondria from different rat brain regions and dose-dependently down-regulates complex I activity Neuroscience Letters 2009 454 3 187 192
87. Devi L., Raghavendran V., Prabhu B. M., Avadhani N. G., Anandatheerthavarada H. K., Mitochondrial import and accumulation of -synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain Journal of Biological Chemistry 2008 283 14 9089 9100
88. Banerjee K., Sinha M., Pham C. L. L., Jana S., Chanda D., Cappai R., Chakrabarti S., α-synuclein induced membrane depolarization and loss of phosphorylation capacity of isolated rat brain mitochondria: implications in Parkinson's disease FEBS Letters 2010 584 8 1571 1576
89. Kamp F., Exner N., Lutz A. K., Wender N., Hegermann J., Brunner B., Nuscher B., Bartels T., Giese A., Beyer K., Eimer S., Winklhofer K. F., Haass C., Inhibition of mitochondrial fusion by -synuclein is rescued by PINK1, Parkin and DJ-1 EMBO Journal 2010 29 20 3571 3589
90. Martin L. J., Pan Y., Price A. C., Sterling W., Copeland N. G., Jenkins N. A., Price D. L., Lee M. K., Parkinson's disease -synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death Journal of Neuroscience 2006 26 1 41 50 (Pubitemid 43089519)
91. Chau K. Y., Ching H. L., Schapira A. H. V., Cooper J. M., Relationship between alpha synuclein phosphorylation, proteasomal inhibition and cell death: relevance to Parkinson's disease pathogenesis Journal of Neurochemistry 2009 110 3 1005 1013
92. Krebiehl G., Ruckerbauer S., Burbulla L. F., Kieper N., Maurer B., Waak J., Wolburg H., Gizatullina Z., Gellerich F. N., Woitalla D., Riess O., Kahle P. J., Proikas-Cezanne T., Krger R., Reduced basal autophagy and impaired mitochondrial dynamics due to loss of Parkinson's disease-associated protein DJ-1 PLoS ONE 2010 5 2, article e9367
93. Irrcher I., Aleyasin H., Seifert E. L., Hewitt S. J., Chhabra S., Phillips M., Lutz A. K., Rousseaux M. W.C., Bevilacqua L., Jahani-Asl A., Callaghan S., MacLaurin J. G., Winklhofer K. F., Rizzu P., Rippstein P., Kim R. H., Chen C. X., Fon E. A., Slack R. S., Harper M. E., McBride H. M., Mak T. W., Park D. S., Loss of the Parkinson's disease-linked gene DJ-1 perturbs mitochondrial dynamics Human Molecular Genetics 2010 19 19 3734 3746
94. Lutz A. K., Exner N., Fett M. E., Schleke J. S., Kloos K., Lmmermann K., Brunner B., Kurz-Drexler A., Vogel F., Reichert A. S., Bouman L., Vogt-Weisenhorn D., Wurst W., Tatzelt J., Haass C., Winklhofer K. F., Loss of parkin or PINK1 function increases Drp1-dependent mitochondrial fragmentation Journal of Biological Chemistry 2009 284 34 22938 22951
95. Sandebring A., Thomas K. J., Beilina A., van der Brug M., Cleland M. M., Ahmad R., Miller D. W., Zambrano I., Cowburn R. F., Behbahani H., Cedazo-Mnguez A., Cookson M. R., Mitochondrial alterations in PINK1 deficient cells are influenced by calcineurin-dependent dephosphorylation of dynamin-related protein 1 PLoS ONE 2009 4 5, article e5701
96. Deng H., Dodson M. W., Huang H., Guo M., The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila Proceedings of the National Academy of Sciences of the United States of America 2008 105 38 14503 14508
97. Yang Y., Ouyang Y., Yang L., Beal M. F., McQuibban A., Vogel H., Lu B., Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery Proceedings of the National Academy of Sciences of the United States of America 2008 105 19 7070 7075 (Pubitemid 351754531)
98. Poole A. C., Thomas R. E., Andrews L. A., McBride H. M., Whitworth A. J., Pallanck L. J., The PINK1/Parkin pathway regulates mitochondrial morphology Proceedings of the National Academy of Sciences of the United States of America 2008 105 5 1638 1643 (Pubitemid 351346567)
99. Dagda R. K., Cherra S. J. III, Kulich S. M., Tandon A., Park D., Chu C. T., Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission Journal of Biological Chemistry 2009 284 20 13843 13855
100. Vives-Bauza C., Zhou C., Huang Y., Cui M., De Vries R. L. A., Kim J., May J., Tocilescu M. A., Liu W., Ko H. S., Magran J., Moore D. J., Dawson V. L., Grailhe R., Dawson T. M., Li C., Tieu K., Przedborski S., PINK1-dependent recruitment of Parkin to mitochondria in mitophagy Proceedings of the National Academy of Sciences of the United States of America 2010 107 1 378 383
101. Chu C. T., A pivotal role for PINK1 and autophagy in mitochondrial quality control: implications for Parkinson disease Human Molecular Genetics 2010 19 1 R28 R37
102. Narendra D., Tanaka A., Suen D. F., Youle R. J., Parkin is recruited selectively to impaired mitochondria and promotes their autophagy Journal of Cell Biology 2008 183 5 795 803
103. Kim Y., Park J., Kim S., Song S., Kwon S. K., Lee S. H., Kitada T., Kim J. M., Chung J., PINK1 controls mitochondrial localization of Parkin through direct phosphorylation Biochemical and Biophysical Research Communications 2008 377 3 975 980
104. Narendra D. P., Jin S. M., Tanaka A., Suen D. F., Gautier C. A., Shen J., Cookson M. R., Youle R. J., PINK1 is selectively stabilized on impaired mitochondria to activate Parkin PLoS Biology 2010 8 1, article e1000298
105. Whitworth A. J., Pallanck L. J., The PINK1/Parkin pathway: a mitochondrial quality control system? Journal of Bioenergetics and Biomembranes 2009 41 6 499 503
106. Gegg M. E., Cooper J. M., Chau K.-Y., Rojo M., Schapira A. H. V., Taanman J.-W., Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin- dependent manner upon induction of mitophagy Human Molecular Genetics 2010 19 24 4861 4870
107. Thomas K. J., McCoy M. K., Blackinton J., Beilina A., van der B. M., Sandebring A., DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy Human Molecular Genetics 2010 20 1 40 50
108. Hao L. Y., Giasson B. I., Bonini N. M., DJ-1 is critical for mitochondrial function and rescues PINK1 loss of function Proceedings of the National Academy of Sciences of the United States of America 2010 107 21 9747 9752
109. Plun-Favreau H., Klupsch K., Moisoi N., Gandhi S., Kjaer S., Frith D., Harvey K., Deas E., Harvey R. J., McDonald N., Wood N. W., Martins M. L., Downward J., The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1 Nature Cell Biology 2007 9 11 1243 1252 (Pubitemid 350042356)
110. Strauss K. M., Martins L. M., Plun-Favreau H., Marx F. P., Kautzmann S., Berg D., Gasser T., Wszolek Z., Mller T., Bornemann A., Wolburg H., Downward J., Riess O., Schulz J. B., Krger R., Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease Human Molecular Genetics 2005 14 15 2099 2111 (Pubitemid 41418010)
111. Bogaerts V., Nuytemans K., Reumers J., Pals P., Engelborghs S., Pickut B., Corsmit E., Peeters K., Schymkowitz J., De Deyn P. P., Cras P., Rousseau F., Theuns J., Van Broeckhoven C., Genetic variability in the mitochondrial serine protease HTRA2 contributes to risk for Parkinson disease Human Mutation 2008 29 6 832 840 (Pubitemid 351794134)
112. Pridgeon J. W., Olzmann J. A., Chin L. S., Li L., PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1 PLoS Biology 2007 5 7, article e172
113. Alvarez-Erviti L., Rodriguez-Oroz M. C., Cooper J. M., Caballero C., Ferrer I., Obeso J. A., Schapira A. H.V., Chaperone-mediated autophagy markers in Parkinson disease brains Archives of Neurology 2010 67 12 1464 1472
114. Betarbet R., Sherer T. B., MacKenzie G., Garcia-Osuna M., Panov A. V., Greenamyre J. T., Chronic systemic pesticide exposure reproduces features of Parkinson's disease Nature Neuroscience 2000 3 12 1301 1306
115. Hllerhage M., Matusch A., Champy P., Lombs A., Ruberg M., Oertel W. H., Hglinger G. U., Natural lipophilic inhibitors of mitochondrial complex I are candidate toxins for sporadic neurodegenerative tau pathologies Experimental Neurology 2009 220 1 133 142
116. Schapira A. H. V., Complex I: inhibitors, inhibition and neurodegeneration Experimental Neurology 2010 224 2 331 335
117. Kamel F., Tanner C. M., Umbach D. M., Hoppin J. A., Alavanja M. C. R., Blair A., Comyns K., Goldman S. M., Korell M., Langston J. W., Ross G. W., Sandler D. P., Pesticide exposure and self-reported Parkinson's disease in the agricultural health study American Journal of Epidemiology 2007 165 4 364 374
118. Gu M., Irvani M., Cooper J. M., King D., Jenner P., Schapira A. H. V., Pramipexole protects against apoptotic cell death by non-dopaminergic mechanisms Journal of Neurochemistry 2004 91 5 1075 1081 (Pubitemid 39587446)
119. Shults C. W., Oakes D., Kieburtz K., Flint Beal M., Haas R., Plumb S., Juncos J. L., Nutt J., Shoulson I., Carter J., Kompoliti K., Perlmutter J. S., Reich S., Stern M., Watts R. L., Kurlan R., Molho E., Harrison M., Lew M., Effects of coenzyme Q in early Parkinson disease: evidence of slowing of the functional decline Archives of Neurology 2002 59 10 1541 1550
120. Kieburtz K., Ravina B., Galpern W. R., Tilley B., Shannon K., Tanner C., Wooten G. F., Hamill R., Sage J. I., Kosa E., Watts R. L., Stover N. R., McMurray R., Lew M. F., Kawai C., Coffey D., LeBlanc P., Carter J., Brodsky M., Andrews P., Siderowf A., Reichwein S., Shulman L., Weiner W. J., Pabst K., Jaglin J., Hauser R., McClain T., Delgado H., Suchowersky O., Derwent L., Rao J., Cook M., Aminoff M. J., Christine C., Roth J., Leehey M., Bainbridge J., Ross G. W., Terashita S., Singer C., Perez M. A., Blenke A., Racette B., Deppen P., Elble R., Young C., Stewart T., Sethi K., Dill B., Taylor J., Roberge P., Dewey Jr. R. B., Hayward B., Jankovic J., Hunter C., Wooten F., Keller M. F., Jennings D., Kelsey T., Martin W., McInnes G., Wojcieszek J., Belden J., Albin R., Wernette K., Savitt J., Dunlop B., Pahwa R., Lyons K. E., Parsons A., Fang J., Shearon D., Feigin A., Cox M. M., Adler C., Lind M., Scott B., Field J., Nance M., Peterson S., Burns R. S., Marlor L., Van Bodis-Wollner I., Hayes E., Schneider J., Sendek S., Gollomp S., Vernon G., LeWitt P., DeAngelis M., Simon D., Paul L., Gorell J., Krstevska S., Flewellen M., McCarthy S., Uitti R., Turk M., Bower J., Torgrimson S., Sabbagh M., Obradov Z., Juncos J., Weeks M. L.M., Fernandez H., Brown G., Elm J., Guimaraes P., Huang P., Palesch Y., Kamp C., Shinaman A., Fraser D., Brocht A., Bennett S., Weaver C., Baker D., Olsen B., Goetz C., Miyasaki J., Fagan S., Mauldin P., A randomized clinical trial of